Loading organizations...
Loading organizations...
Key people at HM Capital.
Key people at HM Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 2, 2025 | OncoC4 | $50.0M Series B | GBA Fund | 3E Bioventures Capital, Kaitai Capital |
| Aug 22, 2022 | Porton Advanced Solutions | $80.0M Series B | China Merchants Capital, Merchant Health | CS Capital, Fosun Health Capital, Gortune Investment, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, SDICTK |
| Mar 8, 2022 | Osteal Therapeutics | $30.0M Series B | HM Capital | — |
| Jan 1, 2022 | GenFleet Therapeutics | $78.5M Series C | Zeng Zhiqiang | Baidu Ventures, CDH Investments, Cherami Investment Group, Dyee Capital, Lake Bleu Capital, Panlin Capital, Qiaojing Eastern Investment, Shanjin Asset, Suxin Venture Capital |
| Feb 12, 2021 | 3-V Biosciences | $80.0M Other Equity | — | Altium Capital, Ascletis, Invus, Beth Seidenberg, Matt McAviney, PFM Health Sciences, Rock Springs Capital |
| Sep 9, 2020 | Merck | $56.0M Series B | Robert Luo | Karen Liu, GBA Fund, Kaitai Capital |